Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) PT at $31.46
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fourteen ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1-year price target […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fourteen ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1-year price target […]
